Trial Profile
A study of onabotulinum toxin A for treatment of chronic posttraumatic headache in individuals with mild traumatic brain injury.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Headache
- Focus Therapeutic Use
- 14 Jul 2017 New trial record
- 11 Jun 2017 Results (n=13) presented at the 59th Annual Scientific Meeting of the American Headache Society